Welcome : Guest

Corium International, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Corium International, Inc., which is principally a Commercial Stage Biopharmaceutical Company. Illustrated with 57 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-64134
Price: $2850
Company Type: Public
Pages: 60
Date: November 2016
Market Data Tables: 57

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Corium International, Inc.’s Sales by Contract Research and Development Partners (2014) in Percentage for P&G, Teva, Actavis/Par, Agile, Co-Development Products and Others)......3
Active Pharmaceutical Ingredients (API)......5
Table 2: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for In-House Manufacturing, and Outsourced to CMOs......5
Table 3: Generic Active Pharmaceutical Ingredients Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Avapro Avalide, Benicar HCT, Cozaar Hyzaar, Diovan HCT, and Others......6
Table 4: Active Pharmaceutical Ingredient Market for Small Molecules by Category Worldwide (2015) - Percentage Share Breakdown by Value for Generics (Outsourced), In-House, and Patent-Protected (Outsourced)......7
Table 5: Pharmaceuticals Services and Active Ingredients (PSAI) Segment Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for Europe, India, North America and Rest of the World......8
Table 6: Active Pharmaceutical Ingredients (API) Manufacturers Market by Segment in China (2015) - Percentage Share Breakdown by Value Sales for Biomanufacturing, HPAPI Manufacturing, and Small Molecules API Manufacturing......9
Central Nervous System (CNS) Drugs......10
Table 7: Central Nervous System (CNS) Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Depression, Epilepsy, Narcotic Analgesics, Non-Narcotic Analgesics, Psychotic Disorders and Others......10
Table 8: Central Nervous System Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Anti-Migraine, Antipsychotics, Newer Antidepressants, Older Antidepressants, SNRI's, SSRI’s, Tranquilizers, and Others......11
Pain Drugs......12
Table 9: Pain Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Hydrocordone, Acetaminophen, Lidoderm, Lyrica, OpanaER, Oxycotin, and Others......12
Parkinson's Disease......13
Table 10: Parkinson's Market by Type Worldwide (2015) - Percentage Breakdown by Volume for Mild, Moderate and Severe......13
Table 11: Population Affected with Parkinson's by Age Group in the US (2015) - Percentage Share Breakdown for 65‐69, 70‐74, 75‐79, 80‐84 and 85+......14
Migraine Drugs......15
Table 12: Migraine Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Prescriptions for Amerge Generic (Naratriptan), Imitrex Generic (Sumatriptan), Maxalt Generic (Rizatriptan), Relpax (Pfizer), and Zomig Generic (Zolmitriptan)......15
Antipsychotic Drugs......16
Table 13: Antipsychotic Drugs Market by Disorder in the US (2015) - Percentage Breakdown by Value for Anxiety, Bipolar, Disorder, Major, Depression, Schizoaffective Disorder, Schizophrenia, and Other Indications......16
Table 14: Anti-Psychotics Market Worldwide (2015-2020) in US$ '000......17
Table 15: Prescribed Atypical Antipsychotic Market by Type in the US (2015) - Percentage Share Breakdown by Value for 5HT1A Agonist, H1, Antagonist, D2 and 5HT2, D2 and 5HT2A, and Partial D2 Agonist......18
Pulmonary Arterial Hypertension (PAH)......19
Table 16: Pulmonary Arterial Hypertension (PAH) Treatment by Drug Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Adcirca, Letairis/Volibris, Remodulin, Revatio, Tracleer, Tyvaso and Ventavis......19
Table 17: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy Worldwide (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......20
Table 18: Pulmonary Arterial Hypertension (PAH) Treatment with Macitentan Drug by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Japan, US and Rest of World......21
Table 19: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type Worldwide (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......22
Table 20: Pulmonary Arterial Hypertension (PAH) Treatment by Type Worldwide (2015) - Percentage Breakdown by Value for Inhaled Prostacyclins, Orals (ERAs, PDE5s, Prostacyclins), and Parenteral Prostacyclins......23
Table 21: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in Europe (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......24
Table 22: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in Europe (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......25
Table 23: Pulmonary Arterial Hypertension Treatment Market by Product Segment in Japan (2015) - Percentage Share Breakdown by Value for Adcirca, Dorner, Flolan, Procylin, Revatio, and Tracleer......26
Table 24: Pulmonary Arterial Hypertension (PAH) Treatment by Therapy in the US (2015) - Percentage Market Share Breakdown by Value for ERA Monotherapy, PDE-5 Monotherapy and ERA+PDE-5 Combination Therapy......27
Table 25: Pulmonary Arterial Hypertension (PAH) Treatment with Prostacyclin Therapy by Type in the US (2015) - Percentage Market Share Breakdown by Value for Prostacyclin + ERA, Prostacyclin + PDE-5 and Triple Therapy......28
Contraceptives......29
Table 26: Contraceptives Usage by Method Worldwide (2015) - Percentage Share Breakdown by Value for Condom, Female Sterilization, Intrauterine Device, Pill, Traditional, and Others......29
Hormonal Contraceptive......30
Table 27: Hormonal Contraceptive Market by Category in the US (2015) - Percentage Share Breakdown by Value for Combination Hormonal Tablets, Injectable and Implant, Nuvaring, and Patch......30
Chronic Pain......31
Table 28: No. of Population with Chronic Pain by Age in the US (2015) - Percentage Share Breakdown by Volume for 18 & over and 18 & Under......31
Table 29: No. of Population with Chronic Pain by Type in the US (2015) - Percentage Breakdown by Volume for Back Pain and Other Pain......32
Table 30: Chronic Pain in Adults by Pain Type in the US (2015) - Percentage Share Breakdown by Volume for Knee Pain, Low Back Pain, Serve Headache or Migraine......33
Table 31: No. of People with Chronic Pain in the US (2015-2020) in Million......34
Alzheimer's Disease Drugs......35
Table 32: Market Shares of Leading Alzheimer Disease Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for Forest Laboratories, Inc., Johnson & Johnson, Novartis International AG, Pfizer, Inc., and Others......35
Table 33: Market Shares of Leading Therapeutic Providers (Alzheimer's Disease, Bone Diseases, Cardiology, CNS, Dermatology, Diabetes/Metabolic, Epilepsy, G.I./Ulcer, HBV/HCV, Infectious Disease, Multiple Sclerosis, Obesity, Onc./Hematology, Ophthalmology, Orphan Disease, Pain Management, Respiratory, Rheumatology, Sleep Disorders, Urinary Incont., and Women's Health) by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Biogen Idec, Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Endo International Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......36
Central Nervous System (CNS) Medicines......37
Table 34: Market Shares of Leading Central Nervous System Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc (AZN), Bristol-Myers Squibb Company (BMY), Eli Lilly And Co (LLY), GlaxoSmithKline Plc (GSK), Johnson & Johnson, Merck & Co., Inc. (MRK), Novartis AG (NVS), Pfizer, Inc. (PFE), Shire Plc (SHPGY), and Others......37
Table 35: Market Shares of Leading Central Nervous System (CNS) Medicine Manufacturers by Value Sales in India (2015) - Percentage Breakdown for Torrent Pharmaceuticals Ltd., and Others......38
Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine......39
Table 36: Market Shares of Leading Osteoporosis, Hormone Replacement, & Cancer Bone Loss Medicine Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Amgen, Inc. (AMGN), Eli Lilly And Co (LLY), Merck & Co., Inc. (MRK), Novartis AG (NVS), Sanofi SA (SNY), Warner Chilcott Plc (WCRX), and Others......39
Pain Management Drugs......40
Table 37: Market Shares of Leading Pain Management Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Endo International Plc, Johnson & Johnson, Pfizer, Inc., and Others......40
Table 38: Market Shares of Leading Pain Remedies Manufacturers for Over-the-Counter (OTC) Sector in the US (2015) - Percentage Breakdown by Value for Bayer HealthCare AG, Johnson & Johnson Private Limited, Pfizer, Inc., Prestige Brands Holdings, Inc., Private-label and Others......41
Table 39: Market Shares of Leading Pain Remedy Producers Sales in the US OTC Market (2014) - Percentage Breakdown by Value for Bayer AG, Johnson & Johnson, Novartis AG, Pfizer, Inc., Prestige Brands Holdings, Inc., Private Label and Others......42
Table 40: Market Shares of Leading Oral Pain Relief Brands through Food Store in the US (2015) - Percentage Share Breakdown by Value for Anbesol, Baby Orajel, Kank A, Kank A Softbrush, Orajel, Private Label, and Others......43
Table 41: Market Shares of Leading Oral Pain Relief Brands through Supermarkets, Drugstores, Mass Merchandisers (including Wal-Mart), Gas & Convenience Stores, Military Commissaries, and Select Club and Dollar Retail Chains in the US (2015) - Percentage Share Breakdown by Value for Anbesol, BabyOrajel, Hyland's, KankA, Orajel, and Others......44
Table 42: Market Shares of Leading Oral Pain Remedy Brands by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Share Breakdown for Anbesol, Baby Orajel, Glyoxide, Kank-A, Orajel, Private Label, and Others......45
Antipsychotics......46
Table 43: Anti-Psychotic Market by Drug Type Worldwide (2015) - Percentage Share Breakdown by Value for Abilify, Abilify Maintena, Invega Sustenna, Latuda, Risperdal Consta, Seroquel XR, and Others......46
Table 44: Market Shares of Leading Prescribed Atypical Antipsychotic Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Bristol-Myers Squibb Company, Janssen Pharmaceuticals, Inc., Sunovion Pharmaceuticals, Inc., and Johnson & Johnson Private Limited......47
Table 45: Market Shares of Leading Prescribed Atypical Antipsychotic Brands in the US (2015) - Percentage Share Breakdown by Value for Abilify, Invega, Latuda, Risperdal, Seroquel, and Others......48
Table 46: New Prescription Market for Atypical Antipsychotic Drugs in the US (2015) - Percentage Share Breakdown by Value Sales for Abilify (Otsuka/ Bristol-Myers Squibb Company), Fanapt (Novartis), Geodon (Pfizer, Inc.), Invega (Johnson & Johnson), Latuda (Sunovion), Olanzapine (Generic Zyprexa), Risperidone (Generic Risperdal), Saphris (Merck & Company, Inc.), Seroquel (AstraZeneca Plc), and Zyprexa (Eli Lilly and Company)......49
Narcotic Drugs......50
Table 47: Narcotic Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value Sales for Butorphanol, Daphine Giraldii Nitsche, Dihydrocodeine/Paracetamol and dihydrocodeine, Fentanyl, Morphine, Oxycodone Acetaminophen, Tramadol, and Others......50
Table 48: Narcotic Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Fentanyl, Morphine, Oxycodone, Tramadol and Others......51
Donepezil......52
Table 49: Market Shares of Leading Donepezil Tablet Brands in Brazil (2015) - Percentage Share Breakdown by Value for Pfizer- Eranz, Torrent- Epez, and Others......52
Female Contraception......53
Table 50: Market Shares of Leading Female Contraception Product Manufacturers by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown for Teva Women's Health, Inc., Watson Pharmaceuticals, Inc., and Others......53
Table 51: Market Shares of Leading Female Contraceptive Product Manufacturers by Value Sales through Drug Stores, Food Stores, Mass Merchandisers (including Wal-Mart) in the US (2015) - Percentage Breakdown for Teva Women's Health, Inc., Watson Pharmaceuticals, Inc., Private Label, and Others......54
Male Contraception......55
Table 52: Market Shares of Leading Male Contraception Product Manufacturers by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown for Church and Dwight Co., Reckitt Benckiser Group plc, and Others......55
Emergency Contraception......56
Table 53: Market Shares of Leading Emergency Contraception Manufacturers in China (2015) - Percentage Breakdown by Value for China Resources Zizhu Pharmaceutical Co., Ltd., Shenyang No. 1 Pharmaceutical Factory, Zhejiang Xianju Pharmaceutical Co., Ltd., and Others......56
Contraceptive Products......57
Table 54: Market Shares of Leading Contraceptive Product Manufacturers by Volume Sales in the US (2015) - Percentage Share Breakdown for Church & Dwight Co., Inc., and Others......57
Table 55: Market Shares of Leading Contraceptive Products Manufacturers in the US (2015) - Percentage Share Breakdown by Value for Church & Dwight Co., Inc., and Others......58
Birth Control Pills......59
Table 56: Market Shares of Leading Birth Control Pill Manufacturers by Value Sales through Supermarkets, Drug Stores and Mass Merchandisers (excluding Wal-Mart) in the US (2015) - Percentage Breakdown for Revive Personal Products Company, Teva Women's Health, Inc., Watson Pharmaceuticals, Inc., and Others......59
Table 57: Corium International, Inc.’s Sales by Product (2015) - Percentage Share Breakdown by Value for Clonidine Transdermal System, Contract Research and Development, Crest White Strips, Fentanyl Transdermal System and Others......60